CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
As many as two in every 10001 of us will develop a lipoma during our lives. In the UK in fact, over 4000 are detected each year2. These very common soft tissue lumps are usually non-malignant, and patients are often reassured to hear that they don’t need treatment.
Consultant orthopaedic surgeon and orthopaedic oncologist, at HCA UK’s The Princess Grace Hospital and The Wellington Hospital, Mr Rob Pollock says the frequent presentation of what appear to be lipomas, that is, non-malignant tissue lumps, could be hiding a much more serious concern.
Liposarcomas, or cancerous lumps of soft fatty tissue, need to be identified early, removed promptly and followed up. Sarcoma is a cancer of the connective tissue and can appear in the bone, muscle, blood vessels, nerves or fat. Although rare, sarcoma is a very serious, high-grade cancer that needs early intervention and proper treatment.
"All too often, we’re presented with a sarcoma for urgent removal which is significantly larger than a golf ball – and still growing. This means the key milestones have been missed in terms of early referral. The rule of thumb is if you have a lump that's 3.5cms or more you absolutely can't leave it. The patient needs to have the proper investigations and diagnostics – we should be offering them an MRI.”
Mr Pollock says many of the patients he reviews were initially reassured in primary care that their lump was benign. While the majority will indeed prove to be harmless, he warns that the assumption that all lumps and bumps are "just lipomas" could set a dangerous trend.
“Once a patient has been told they need to have a lump checked out it can be a very stressful experience, and they usually want an answer very quickly,” says Mr Pollock, who chairs the sarcoma MDT for HCA UK and is recognised as a leading international and UK authority on sarcomas."
To help fast-track these referrals, Mr Pollock has joined forces with a leading musculoskeletal radiologist to offer same-day access to multidisciplinary diagnostics, biopsies and consultations at HCA UK’s Elstree Waterfront Outpatients, in North London.
“It’s really important that we offer patients the highest quality care possible for sarcoma treatment and management,” he says. “Although they usually initially present as a small benign lump, sarcomas are extremely aggressive, and the more complex cases require multidisciplinary care.”
Operating on larger tumours can be extremely demanding. The surgical team may include a general surgeon, urologist, plastic surgeon, vascular surgeon and an orthopaedic surgeon. The patient will then need ongoing post-surgery care. Mr Pollock usually shares follow-up treatment with his specialist colleagues at Leaders of Oncology Care, another HCA UK specialist facility.
Working in close collaboration, this expert multidisciplinary team have formed a highly specialist treatment clinic that can offer unrivalled diagnosis and treatments for sarcomas in terms of consultant experience and patient outcomes. One of Mr Pollock’s greatest concerns in the field of sarcomas is how to improve survival rates in line with improvements that have been made in other, more common, cancers.
“Sadly, sarcoma hasn’t seen the huge improvements in drug therapies that, say, breast cancer has benefitted from in recent years. Survival is still between 60% and 70%, which is where it was about 10 years ago, so we need to really offer our patients the best chance possible – and for that early detection is key.
The main thing for primary care, GP referrers is to remember that, if a patient presents with a lump they’re not certain about, it absolutely needs to be checked out as soon as possible. It’s much better to get numerous negative scan results back, than risk one positive diagnosis going undetected.”
Find out more about our orthopaedic services or to book an appointment call us on 020 3733 5966.
Meet the specialist
Mr Rob Pollock is a Consultant Orthopaedic Surgeon who treats and manages hip and knee conditions with extensive experience in first time and revision hip and knee replacements. He also specialises in bone and soft tissue tumours throughout the body and limb salvage surgery for musculo-skeletal tumours. He was elected president of the British Orthopaedic Oncology Society in June 2023 and is the Chair of HCA UK’s Sarcoma Board.
Mr Pollock has published many research papers on joint reconstruction and bone cancer, regularly presents his work at national and international meetings and enjoys teaching. He is a fellow of the Royal College of Surgeons of England, a member of the British Orthopaedic Association, British Hip Society, British Association for Surgery of the Knee, British Orthopaedic Oncology Society and the European Musculo-Skeletal Oncology Society.
In his spare time, he regularly competes in triathlons. Mr Pollock meets patients at a couple of HCA UK’s hospitals and outpatient centres; in north London at The Wellington Hospital’s outpatient centre in Elstree and in central London at The Princess Grace Hospital.